PatientsLikeMe ™

MS
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
MS
Find out more about the PatientsLikeMe
MS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Rebif

What is Interferon beta-1a SubQ injection? Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

1234 patients in the community are taking or have taken Interferon beta-1a SubQ injection.

Reason # Patients Percentage of patients
Slow my MS progress 1025 83%
Other 43 3%
Stiffness/spasticity 14 1%
Fatigue 13 1%
General health 12 <1%
disease-related symptoms 10 <1%
Don't know 5 <1%
Support another treatment 2 <1%
Pain 2 <1%
Anxiety 1 <1%
Depression 1 <1%
Balance problems 1 <1%
Excessive daytime sleepiness (somnolence) 1 <1%
Emotional lability 1 <1%
Weakness/slowness (asthenia) 1 <1%
Treat my MSA 1 <1%
Cognition 1 <1%
Vision 1 <1%
Sensation 1 <1%
Mobility 1 <1%
MS 1 <1%

Dosages

Based on the patients currently taking Interferon beta-1a SubQ injection.

Top 10 (Show all)

All (Show Top 10)

  0 - As needed 0 - Daily 0 mcg Daily 0 mg Daily 0 - Weekly 0 mcg Weekly 0 mg Weekly 0 Weekly 0 mcg 0 mg 0 0 mcg 0.44 mg As needed 22 mcg As needed 44 mcg All the time (24/7) 44 mcg As needed 44 mg As needed 44 mcg Daily 132 mcg Weekly 0.14 mcg 0.44 mg Weekly 0.5 mcg Weekly 0.5 mg Weekly 0.22 mg 0.25 mcg 0.25 mg 1 g Weekly 1 Weekly 0.3 mcg 0.3 mg 1.1 Weekly 0.44 mcg 0.5 mcg 0.44 mcg 0.44 mg 0.44 0.5 mcg 0.5 mg 0.3 mcg Daily 0.3 mg Daily 0.8 mcg 0.75 mg 1 mcg 3 mcg Weekly 3 mg Weekly 3 Weekly 1 mcg 1 mg 1 4.4 mcg Weekly 2.2 mcg 1 mL Daily 8.8 mcg Weekly 3 mcg 3 mcg 3 mg 4.4 mcg 15 mcg Weekly 20 mg Weekly 3 mg Daily 22 mcg Weekly 22 mg Weekly 24 mcg Weekly 26.4 mcg Weekly 10 mcg 30 mcg Weekly 30 mg Weekly 132 mcg Monthly 8.8 mg 33 mg Weekly 10 12 mcg 40 mcg Weekly 40.5 mcg Weekly 44 mcg Weekly 44 mg Weekly 44 Weekly 60 mg Weekly 8.8 mcg As needed 22 mcg Daily 22 mcg 66 mcg Weekly 66 mg Weekly 10 mg Daily 20 mcg 20 mg 22 mcg 22 mg 22 25 mg 88 mcg Weekly 30 mcg 33 mcg 30 mcg Daily 30 mcg 112 mcg Weekly 40 mcg 120 mg Weekly 528 mcg Monthly 126 mcg Weekly 44 mcg As needed 44 mcg Daily 44 mcg Weekly 44 mcg 132 mcg Daily 132 mcg Weekly 132 mg Weekly 132 Weekly 134 mcg Weekly 40 mcg 40 41 mcg 43 mg 152 mg Weekly 22 mcg Daily 44 mcg As needed 44 mcg Daily 44 g 44 mcg 44 mg 44 176 mcg Weekly 30 mcg Daily 100 mcg 300 Weekly 44 mg All the time (24/7) 44 mcg As needed 44 mcg Daily 44 mcg Weekly 132 mcg Weekly 132 mcg 138 mcg 144 mcg 125 66 mcg Weekly 132 mcg Weekly 132 mcg 144 mg 100 mcg Daily 200 mcg 200 mg 132 mcg Daily 132 mcg Weekly 132 mg Weekly 321 mcg 300 mg 200 g Daily 250 mcg Daily 500 mcg 300 other Daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 6 Number of Patients: 6 5 Number of Patients: 5 1 Number of Patients: 1 15 Number of Patients: 15 2 Number of Patients: 2 21 Number of Patients: 21 26 Number of Patients: 26 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 10 Number of Patients: 10 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 8 Number of Patients: 8 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 57 Number of Patients: 57 18 Number of Patients: 18 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 10 Number of Patients: 10 11 Number of Patients: 11 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 102 Number of Patients: 102 1 Number of Patients: 1 98 Number of Patients: 98 16 Number of Patients: 16 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 4 Number of Patients: 4 2 Number of Patients: 2 44 Number of Patients: 44 83 Number of Patients: 83 22 Number of Patients: 22 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 48 Number of Patients: 48 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Interferon beta-1a SubQ injection or how long patients were taking Interferon beta-1a SubQ injection before stopping.

Currently taking Interferon beta-1a SubQ injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
22
40
47
80
115
183

Stopped taking Interferon beta-1a SubQ injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
15
46
49
73
62
107
Why Patients Stopped Taking Interferon beta-1a SubQ injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 195 54% Side effects too severe: 54%
Did not seem to work 108 30% Did not seem to work: 30%
Doctor's advice 76 21% Doctor's advice: 21%
Other 61 17% Other: 17%
Personal research 16 4% Personal research: 4%
Not indicated 13 4% Not indicated: 4%
Expense 12 3% Expense: 3%
Course of treatment ended 6 2% Course of treatment ended: 2%

Patient Reported Evaluations

Results from 100 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 14% 13
Moderate 11% 10
Slight 10% 9
None 13% 12
Can't tell 52% 48

Slow my MS progress

Side-effects (as an overall problem)

Severe 16% 16
Moderate 39% 39
Mild 34% 34
None 11% 11

Top reported side-effects include: Muscle ache, whole body, injection site redness, Chills/fever

Summary results are based on 100 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 100)

  • jeannadebello23
    Sex: F
    Sensation: Moderate
    Overall: Severe
    Cognition: severe
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: moderate
    Walking: severe
    See profile
  • jeannadebello23
  • by jeannadebello23
    Mar 23, 1990
  • EfficacyNone
  • Side-effectsSevere
  • Stiffness/spasticity

  • SAR1965
    Sex: F
    Sensation: Moderate
    Overall: Mild
    Cognition: mild
    Vision: none
    Speech: none
    Swallowing: mild
    Upper limb: mild
    Walking: moderate
    See profile
  • by SAR1965
    Aug 29, 2008